Mytos
A Principal PD/MSAT Scientist at Mytos Bio leads process development and analytical method projects for cell therapy manufacturing at their CDMO site. This role drives automation and technology transfer while supporting business development through direct client engagement. The successful candidate will mentor colleagues and deliver complex projects spanning the pre-clinical to cGMP pipeline.
Headquarters
London, England, United Kingdom
Company Size
11-50 employees
Founded
2016
Mytos is an automated regenerative medicine CDMO that helps scale cell- and tissue-based therapies. Its proprietary iDEM automation platform standardizes and automates manufacturing to deliver faster, more reproducible, and cost-efficient production at clinical and commercial scale. Mytos partners with biotech developers to manufacture cell therapies across indications (recent deals include programs for bone fractures, deafness, and corneal blindness). Their mission is to enable millions of patients to access regenerative medicine by bringing industrial‑scale automation and GMP manufacturing to complex living therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Mytos.
Mytos didn’t post a salary, so this is our estimate from similar listings.
15% above the average for this role
Associate Scientist, Quality Control (QC)
Cartesian Therapeutics
Senior Research Scientist
Applied Biological Materials (abm)
Scientist I, Molecular and Cellular Biology
Catalent
OmniaBio: Associate Scientist (MSAT)
OmniaBio
Director, MSAT
Sana Biotechnology
Analytical Scientist MSAT
Massachusetts General Hospital